ABL Bio Market Cap

ABL Bio has a market cap or net worth of 3.44 trillion as of June 20, 2025. Its market cap has increased by 191.62% in one year.

Market Cap

3.44T

Enterprise Value

3.37T

Revenue

27.63B

Ranking

n/a

PE Ratio

n/a

Stock Price

70,800.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 3.44T, an increase of 464.53%. That is a compound annual growth rate of 30.47%.

Market Cap History

Date	Market Cap	% Change
Jun 20, 2025	3,435.78B	138.00%
Dec 30, 2024	1,443.63B	22.53%
Dec 28, 2023	1,178.16B	7.19%
Dec 29, 2022	1,099.13B	5.54%
Dec 30, 2021	1,041.42B	-27.59%
Dec 30, 2020	1,438.26B	31.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.31T
Celltrion	35.87T
ALTEOGEN	20.84T
Yuhan	7,750.90B
SK Biopharmaceuticals	7,275.30B
HLB Co., Ltd.	7,017.40B
PharmaResearch	4,748.07B
Peptron	4,647.82B

Market Cap Rankings